Entegris Extends Life Sciences Production Facilities

• Semiconductor supplier Entegris Inc (NASDAQ: ENTG) has expanded its Life Sciences manufacturing facilities in Billerica, MA; Bloomington, MN, and Logan, UT.

• The expansions are part of Entegris' Capex plan to invest $30 million in life sciences volume and abilities in 2021, apart from the $10 million investment in 2020.

• The facilities will develop and manufacture bioprocessing assemblies like Aramus critical fluid handling product lines currently used to produce and deliver vaccines globally.

• Entegris plans to hire around 200 additional employees with engineering and production experience throughout 2021.

• Entegris also has started developing its Life Sciences Technology Center in Billerica, MA.

• The facility will provide application testing, process development, and solution demonstration services for bioprocess technologies, including freeze, thaw, and filtration applications.

• Price action: ENTG shares traded lower by 1.02% at $115.04 on the last check Monday.

See more from Benzinga

• Click here for options trades from Benzinga

• Facebook to Forego Creator Commission Till 2023, Charge Lower Commission than Apple

• Apple's Introduces FaceTime Calls with Multiple Users, Adds Android, Windows Compatibility: Reuters

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.